| Symrise AG. (2/29/24). "Press Release: Dr Jean-Yves Parisot Assumes CEO Position from Dr Heinz-Jürgen Bertram". Holzminden. |
2024-02-29 |
| AZMed SAS. (2/20/24). "Press Release: AZmed Secures €15 Million to Shape the Future of Medical Imaging with AI". Paris. |
2024-02-20 |
| Valneva S.E.. (11/10/23). "Press Release: Valneva Announces U.S. FDA Approval of World’s First Chikungunya Vaccine, Ixchiq". Saint Herblain. |
2023-11-10 |
| Valneva S.E.. (11/9/23). "Press Release: Valneva Reports Nine-Month 2023 Financial Results and Provides Corporate Updates". Saint Herblain. |
2023-11-09 |
| Valneva S.E.. (11/7/23). "Press Release: Valneva to Present and Hold Investor Meetings at the Jefferies London Healthcare Conference". Saint Herblain. |
2023-11-07 |
| Valneva S.E.. (10/25/23). "Press Release: Valneva Submits Chikungunya Vaccine Marketing Application to EMA and Announces CHMP Accelerated Assessment". Saint Herblain. |
2023-10-25 |
| Valneva S.E.. (9/25/23). "Press Release: Valneva Announces New Ixiaro Supply Contract with the U.S. Government Worth a Minimum of $32 Million". Saint Herblain. |
2023-09-25 |
| iOmx Therapeutics AG. (9/5/23). "Press Release: iOmx Therapeutics Appoints Dr. Nils Peter Debus as Chief Business Officer". Martinsried. |
2023-09-05 |
| Valneva S.E.. (11/17/22). "Press Release: Valneva Appoints Dipal Patel as Chief Commercial Officer". Saint-Herblain. |
2022-11-17 |
| OSE Immunotherapeutics S.A.. (10/7/22). "Press Release: OSE Immunotherapeutics Appoints Nicolas Poirier as Chief Executive Officer". Nantes. |
2022-10-07 |
| Valneva S.E.. (10/4/22). "Press Release: Valneva Announces Closing of Upsized €102.9 Million Global Offering". Saint-Herblain. |
2022-10-04 |
| Valneva S.E.. (8/18/22). "Press Release: Valneva Provides Update on Ixiaro Supply Contract with U.S. Department of Defense". Saint-Herblain. |
2022-08-18 |
| Valneva S.E.. (8/8/22). "Press Release: Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15". New York, NY & Saint-Herblain. |
2022-08-08 |
| Valneva S.E.. (8/1/22). "Press Release: Valneva Confirms Amendment of Advance Purchase Agreement with European Commission for Valneva’s Inactivated COVID-19 Vaccine". Saint-Herblain. |
2022-08-01 |
| Valneva S.E.. (7/20/22). "Press Release: European Commission Approves Purchase Agreement Amendment for Valneva’s Inactivated COVID-19 Vaccine". Saint-Herblain. |
2022-07-20 |
| Valneva S.E.. (6/24/22). "Press Release: Valneva Receives Marketing Authorization in Europe for Inactivated Whole-Virus COVID-19 Vaccine VLA2001". Saint-Herblain. |
2022-06-24 |
| Valneva S.E.. (6/23/22). "Press Release: Valneva and Pfizer Announce Closing of Equity Investment". Saint-Herblain & New York, NY. |
2022-06-23 |
| Valneva S.E.. (6/20/22). "Press Release: Valneva and Pfizer Enter into an Equity Subscription Agreement and Update Terms of Collaboration Agreement for Lyme Disease Vaccine Candidate VLA15". Saint-Herblain & New York, NY. |
2022-06-20 |
| Valneva S.E.. (5/16/22). "Press Release: Valneva Receives Notice of European Commission’s Intent to Terminate COVID-19 Vaccine Purchase Agreement". Saint-Herblain. |
2022-05-16 |
| Valneva S.E.. (4/25/22). "Press Release: Valneva Provides Regulatory Update on its inactivated COVID-19 Vaccine Candidate". Saint-Herblain. |
2022-04-25 |
| SeaBeLife SAS. (3/14/22). "Press Release: SeaBeLife Receives Close to €1.4M Deep Tech Financing from Bpifrance". Roscoff. |
2022-03-14 |
| European Invesmtent Bank (EIB). (12/15/21). "Press Release: France – EIB Provides €15 Million to Robocath to Support the Development of Its Robotic Solutions for Treating Cardiovascular Disease". |
2021-12-15 |
| Valneva S.E.. (11/23/21). "Press Release: Valneva Signs Purchase Agreement with European Commission for its Inactivated COVID-19 Vaccine VLA2001". Saint-Herblain. |
2021-11-23 |
| Valneva S.E.. (11/10/21). "Press Release: Valneva Announces European Commission Approval of Advance Purchase Agreement for up to 60 Million Doses of Inactivated COVID-19 Vaccine VLA2001". Saint-Herblain. |
2021-11-10 |
| Valneva S.E.. (11/8/21). "Press Release: Valneva to Present and Hold Investor Meetings at the Jefferies London Healthcare Conference". Saint-Herblain. |
2021-11-08 |
| Valneva S.E.. (10/29/21). "Press Release: Valneva Announces the Pricing of its Global Offering of American Depositary Shares and Ordinary Shares". Saint-Herblain. |
2021-10-29 |
| Valneva S.E.. (10/26/21). "Press Release: Valneva Announces Launch of Proposed Global Offering of American Depository Shares and Ordinary Shares". Saint-Herblain. |
2021-10-26 |
| Valneva S.E.. (10/18/21). "Press Release: Valneva Reports Positive Phase 3 Results for Inactivated, Adjuvanted COVID-19 Vaccine Candidate VLA2001". Saint-Herblain. |
2021-10-18 |
| Clean Cells SAS. (9/15/21). "Press Release: Clean Cells Invests over €13M in New Biopharmaceutical Production Site". Montaigu-Vendée, near Nantes. |
2021-09-15 |
| Valneva S.E.. (9/13/21). "Press Release: Valneva Receives Notice of Termination of COVID-19 Vaccine Supply Agreement by UK Government". Saint-Herblain. |
2021-09-13 |
| Valneva S.E.. (9/3/21). "Press Release: Valneva – U.S. DoD Exercises First Year Option on Ixiaro Supply Contract". Saint-Herblain. |
2021-09-03 |
| Valneva S.E.. (8/23/21). "Press Release: Valneva Commences Rolling Submission to MHRA for its Inactivated, Adjuvanted COVID-19 Vaccine". Saint-Herblain. |
2021-08-23 |
| Valneva S.E.. (8/11/21). "Press Release: Valneva Initiates Further Phase 3 Clinical Trial for its COVID-19 Vaccine Candidate". Saint-Herblain. |
2021-08-11 |
| Valneva S.E.. (7/29/21). "Press Release: Valneva Appoints Peter Buhler as Chief Financial Officer". Saint-Herblain. |
2021-07-29 |
| Valneva S.E.. (7/6/21). "Press Release: Valneva Strengthens Management Team, Appoints Vincent Dequenne as SVP Operations and Joshua Drumm as VP Investor Relations". Saint-Herblain. |
2021-07-06 |
| Xenothera. (6/29/21). "Press Release: French Biotech Xenothera Accelerates Its Development with Fundraising of 20 Million Euros". Nantes. |
2021-06-29 |
| SeaBeLife SAS. (5/28/21). "Press Release: SeaBeLife Biotech Raises € 1 Million to Carry On Its Drug Developments Targeting Regulated Cell Death". Roscoff. |
2021-05-28 |
| Valneva S.E.. (5/11/21). "Press Release: Valneva Announces Closing of $107.6 Million Global Offering". Saint-Herblain. |
2021-05-11 |
| Valneva S.E.. (5/10/21). "Press Release: Valneva Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Global Offering to $107.6 Million". Saint-Herblain. |
2021-05-10 |
| Valneva S.E.. (5/6/21). "Press Release: Valneva Announces the Pricing of its Initial Public Offering on Nasdaq". Saint-Herblain. |
2021-05-06 |
| Valneva S.E.. (4/29/21). "Press Release: Valneva Announces Launch of Proposed Global Offering, Start of the Roadshow and Nasdaq Listing". Saint-Herblain. |
2021-04-29 |
| Valneva S.E.. (4/6/21). "Press Release: Valneva Reports Positive Phase 1/2 Data for Its Inactivated, Adjuvanted COVID-19 Vaccine Candidate, VLA2001". Saint-Herblain. |
2021-04-06 |
| CureVac N.V.. (12/9/20). "Press Release: CureVac and Fareva Sign Agreement for Fill & Finish Manufacturing of Curevac’s COVID-19 Vaccine Candidate, CVnCoV". Tübingen & Boston, MA. |
2020-12-09 |
| Valneva S.E.. (11/10/20). "Press Release: Valneva Announces Plans for Extraordinary General Meeting to Prepare for Potential US IPO". Saint-Herblain. |
2020-11-10 |
| Robocath SAS. (11/2/20). "Press Release: Robocath Finalizes Creation of the Joint Venture with MicroPort through Its Medical Robotic Subsidiary MedBot". Rouen. |
2020-11-02 |
| Dinaqor AG. (9/16/20). "Press Release: Dinaqor AG Appoints Eduard Ayuso as Chief Technology Officer". Pfäffikon. |
2020-09-16 |
| Valneva S.E.. (9/9/20). "Press Release: Valneva Announces New Ixiaro Supply Contract with the US Government Worth up to $166 Million". Saint-Herblain. |
2020-09-09 |
| Valneva S.E.. (9/8/20). "Press Release: Valneva Initiates Phase 3 Clinical Study for its Chikungunya Vaccine Candidate VLA1553". Saint-Herblain. |
2020-09-08 |
| SeaBeLife SAS. (6/19/20). "Press Release: SeaBeLife Biotech Raises € 1.5 Million to Develop Drugs Targeting Regulated Cell Death". Roscoff. |
2020-06-19 |
| Valneva S.E.. (6/18/20). "Press Release: Valneva and Bavarian Nordic Announce Marketing and Distribution Partnership". Saint-Herblain. |
2020-06-18 |
| Valneva S.E.. (4/30/20). "Press Release: Valneva and Pfizer Announce Collaboration to Co-Develop and Commercialize Lyme Disease Vaccine, VLA15". Saint-Herblain & New York, NY. |
2020-04-30 |
| Robocath SAS. (4/29/20). "Press Release: Robocath Secures €40 Million Series C Financing Round to Deploy Its Operations Development Plan". Rouen. |
2020-04-29 |
| Valneva S.E.. (4/22/20). "Press Release: Valneva and Dynavax Announce Collaboration to Advance Vaccine Development for COVID-19". Saint-Herblain & Emeryville, CA. |
2020-04-22 |
| OSE Immunotherapeutics S.A.. (2/12/20). "Press Release: OSE Immunotherapeutics Announces Artificial Intelligence Antibody Drug Development Collaboration with MAbSilico". Nantes. |
2020-02-12 |
| Valneva S.E.. (2/3/20). "Press Release: Valneva Announces New $85 Million Financing Arrangement with Leading US Healthcare Funds Deerfield and OrbiMed". Saint-Herblain. |
2020-02-03 |
| Valneva S.E.. (1/14/20). "Press Release: US DoD Exercises Option on Ixiaro Supply Contract Bringing Total Value to $70 Million". Saint-Herblain. |
2020-01-14 |
| Valneva S.E.. (1/9/20). "Press Release: Valneva Expands its Commercial Operations with the Opening of its French Commercial Office". Saint-Herblain. |
2020-01-09 |
| Valneva S.E.. (12/20/19). "Press Release: Valneva Completes Delisting from the Vienna Stock Exchange". Saint-Herblain. |
2019-12-20 |
| Acticor Biotech SAS. (11/6/19). "Press Release: Acticor Biotech Raises €7m in Addition to Its Series B Financing, Now Completed at €22.3m". Paris. |
2019-11-06 |
| Theranexus S.A.. (4/9/19). "Press Release: Theranexus Announces Research Collaboration with IRISA Using Artificial Intelligence Technologies to Enhance Therapeutic Targeting of Neurological Interactions". Lyon. |
2019-04-09 |
| OSE Immunotherapeutics S.A.. (2/7/19). "Press Release: OSE Immunotherapeutics and Servier Announce First Option within Global License Agreement Exercised for further Clinical Development and Potential Commercialisation of OSE-127 in Autoimmune Diseases". |
2019-02-07 |
| Valneva S.E.. (1/16/19). "Press Release: Valneva Announces New $59 Million Ixiaro Supply Contract with US Government". Saint-Herblain. |
2019-01-16 |
| Valneva S.E.. (1/7/19). "Press Release: Valneva Announces Its Intention to Delist from the Vienna Stock Exchange. Trading Will Be Centralized on Euronext Paris". Saint-Herblain. |
2019-01-07 |
| Valneva S.E.. (1/7/19). "Press Release: Valneva Reports Positive Phase 1 Interim Results for Its Chikungunya Vaccine Candidate". Saint-Herblain. |
2019-01-07 |
| Valneva S.E.. (12/21/18). "Press Release: Valneva Awarded FDA Fast Track Designation for Chikungunya Vaccine Candidate". Saint-Herblain. |
2018-12-21 |
| Valneva S.E.. (12/17/18). "Press Release: Valneva Initiates Phase 2 Clinical Development For Its Lyme Disease Vaccine Candidate". Saint-Herblain. |
2018-12-17 |
| Valneva S.E.. (12/6/18). "Press Release: Valneva and Hookipa Sign a Collaboration and Manufacturing Agreement". Saint-Herblain & Vienna. |
2018-12-06 |
| Valneva S.E.. (9/27/18). "Press Release: Valneva Raises €50 Million in Oversubscribed Placement Led by US Healthcare Investors [Not for Distribution in the United States, Canada, Australia or Japan]". Saint-Herblain. |
2018-09-27 |
| Valneva S.E.. (9/26/18). "Press Release: Valneva Launches a Capital Increase of Approximately €40 Million [Not for Distribution in the United States, Canada, Australia or Japan]". Saint-Herblain. |
2018-09-26 |
| Valneva S.E.. (9/20/18). "Press Release: Valneva Announces Extension of Drawdown Period for Its Existing European Investment Bank Loan". Saint-Herblain. |
2018-09-20 |
| SenzaGen AB. (7/16/18). "Press Release: SenzaGen Signs Distribution Agreement with the French Test Laboratory Eurosafe". Lund. |
2018-07-16 |
| Sophia Genetics S.A.. (6/16/18). "Press Release: Sophia Genetics Acquires Interactive Biosoftware to Drive Growth and Accelerate Data-Driven Medicine Adoption Around the World". Milan. |
2018-06-16 |
| Eurofins Scientific. (4/4/18). "Press Release: Eurofins Expands Its Offering in Radioactivity and Environmental Testing for the Nuclear Industry with the Acquisition of Eichrom Laboratoires in France". |
2018-04-04 |
| Boehringer Ingelheim. (4/4/18). "Press Release: Boehringer Ingelheim and OSE Immunotherapeutics Announce Global Immuno-Oncology Partnership to Develop a Pioneering Checkpoint Inhibitor for the Treatment of Advanced Solid Tumors". Ingelheim & Nantes. |
2018-04-04 |
| Valneva S.E.. (2/26/18). "Press Release: Emergent BioSolutions and Valneva Initiate Phase 1 Clinical Study to Evaluate Vaccine Candidate against Zika Virus". Gaithersburg, MD & Lyon. |
2018-02-26 |
| Pherecydes Pharma S.A.. (1/16/18). "Press Release: Pherecydes Pharma Raises €8.7m ($10.3m). Series B Financing Led by GO CAPITAL and Two Historical Investors, ACE Management and Auriga Partners". Romainville. |
2018-01-16 |
| Robocath SAS. (12/6/17). "Press Release: Robocath Raises a Total of €6.4 million ($7.6M) in 2017". |
2017-12-06 |
| Valneva S.E.. (11/9/17). "Press Release: Valneva Reports Strong Operational Performance for the First Nine Months of 2017". Lyon. |
2017-11-09 |
| Valneva S.E.. (11/7/17). "Press Release: Valneva Signs $39.6 Million Ixiaro Supply Contract with US Government". Lyon. |
2017-11-07 |
| Sanofi S.A.. (10/12/17). "Press Release: Sanofi Invests €170 Million in New Vaccine Production Facility in France". Paris. |
2017-10-12 |
| OSE Immunotherapeutics S.A.. (9/7/17). "Press Release: OSE Immunotherapeutics Reports on First-Half 2017 Financial Results and Provides Update on Clinical Advances of its Product Portfolio". Nantes. |
2017-09-07 |
| Valneva S.E.. (8/1/17). "Press Release: Valneva Announces Expansion of its Management Board – Strengthening Senior Management for Future Growth". Lyon. |
2017-08-01 |
| Valneva S.E.. (7/24/17). "Press Release: Valneva Receives FDA Fast Track Designation for Its Lyme Disease Vaccine Candidate VLA15". Lyon. |
2017-07-24 |
| OSE Immunotherapeutics S.A.. (7/19/17). "Press Release: OSE Immunotherapeutics Receives €9.2 Million Grant from Bpifrance “Invest in the Future Program” for Development of New Immune Checkpoint Inhibitor OSE-172 (Effi-DEM)". Nantes. |
2017-07-19 |
| Genfit S.A.. (6/23/17). "Press Release: Genfit Reaches a Critical Milestone towards the Development of a Non-invasive In Vitro Diagnostic (IVD) Test for NASH". Lille & Cambridge, MA. |
2017-06-23 |
| Selexis S.A.. (5/23/17). "Press Release: Selexis SA and OSE Immunotherapeutics Sign Commercial License Agreement to Further Advance Development of OSE’s Interleukin Receptor 7 Antagonist". Geneva & Nantes. |
2017-05-23 |
| Robocath SAS. (5/18/17). "Press Release: Robocath Raises €4.7 million ($5.2M) to Market Its First Medical Robotic Platform, R-one, in 2018". Rouen. |
2017-05-18 |
| Hookipa Biotech AG. (4/19/17). "Press Release: Reinhard Kandera Appointed Chief Financial Officer of Hookipa Biotech". Vienna. |
2017-04-19 |
| Eurofins Scientific. (3/21/17). "Press Release: Eurofins and USP Announce Collaboration to Tackle Food Fraud". |
2017-03-21 |
| Valneva S.E.. (2/23/17). "Press Release: Valneva Reports Strong Q4 and FY 2016 Business Performance, Expects Further Growth in Sales and EBITDA, R&D Progress in 2017". Lyon. |
2017-02-23 |
| OSE Immunotherapeutics S.A.. (2/7/17). "Press Release: OSE Immunotherapeutics to Present Corporate Overview at Upcoming BIO CEO & Investor Conference New York February 13-14, 2017". Nantes. |
2017-02-07 |
| IntegraGen S.A.. (2/3/17). "Press Release: IntegraGen Announces Successful Completion of a € 3.7 Million Capital Increase". Évry. |
2017-02-03 |
| McDermott Will & Emery. (1/6/17). "Press Release: McDermott Will & Emery Advised Servier in Its License Option Agreement with OSE Immunotherapeutics". Paris. |
2017-01-06 |
| Valneva S.E.. (1/5/17). "Press Release: Valneva Announces a New Research License Agreement with MSD Animal Health for the Development of Vaccines in the EB66 Cell Line". Lyon. |
2017-01-05 |
![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo.svg){kind=logo}
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
